AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 12358241 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic hemoclip
Number of subjects: 80
Study 12358241 — intervention group
Group type: COMPARATOR
Intervention: Heater probe thermocoagulation
Number of subjects: 80
Study 9695587 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant laferon therapy (intraperitoneal and systemic administration)
Number of subjects: 0
Study 8077355 — intervention group
Group type: COMPARATOR
Intervention: 0.2 mg/kg L-692,429, i.v. preceded by 4 days of prednisolone (20 mg, orally, three times daily)
Number of subjects: 9
Study 8077355 — intervention group
Group type: COMPARATOR
Intervention: 0.75 mg/kg L-692,429 preceded by prednisolone only
Number of subjects: 9
Study 8077355 — intervention group
Group type: COMPARATOR
Intervention: 0.2 mg/kg L-692,429 in the absence of steroid
Number of subjects: 9
Study 2491941 — intervention group
Group type: EXPERIMENTAL
Intervention: (-)-deprenyl (30 mg/d)
Number of subjects: 100
Study 2491941 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 58269 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening for hypertension
Number of subjects: 2420
Study 58269 — intervention group
Group type: EXPERIMENTAL
Intervention: Antihypertensive treatment
Number of subjects: 2420
Study 58269 — intervention group
Group type: COMPARATOR
Intervention: Blood-pressure levels in screening population
Number of subjects: 2420
Study 58269 — intervention group
Group type: COMPARATOR
Intervention: General practitioner visits
Number of subjects: 2420
Study 31068063 — intervention group
Group type: EXPERIMENTAL
Intervention: VTC-administered ADAS-cog
Number of subjects: 73
Study 31068063 — intervention group
Group type: COMPARATOR
Intervention: FTF-administered ADAS-cog
Number of subjects: 73
Study 29357947 — intervention group
Group type: EXPERIMENTAL
Intervention: Auto-adjusting CPAP (APAP) + standard care
Number of subjects: 60
Study 29357947 — intervention group
Group type: COMPARATOR
Intervention: Standard care alone
Number of subjects: 60
Study 27590681 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise training intervention (3 times per week for 6 months)
Number of subjects: 30
Study 27590681 — intervention group
Group type: COMPARATOR
Intervention: Control group without exercise
Number of subjects: 30
Study 24258468 — intervention group
Group type: COMPARATOR
Intervention: Strefen lozenges
Number of subjects: 320
Study 24258468 — intervention group
Group type: COMPARATOR
Intervention: Siccoral spray
Number of subjects: 320
Study 24258468 — intervention group
Group type: COMPARATOR
Intervention: Stomatovis gargle
Number of subjects: 320
Study 24258468 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 320
Study 22023081 — intervention group
Group type: EXPERIMENTAL
Intervention: Haberlea extract (3% in cream)
Number of subjects: 20
Study 20075143 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitagliptin (100 mg)
Number of subjects: 14
Study 18174071 — intervention group
Group type: EXPERIMENTAL
Intervention: Midpalatal implants
Number of subjects: 51
Study 18174071 — intervention group
Group type: COMPARATOR
Intervention: Headgear
Number of subjects: 51
Study 15767770 — intervention group
Group type: EXPERIMENTAL
Intervention: Ammonium hydroxide (AM)
Number of subjects: 20
Study 15767770 — intervention group
Group type: EXPERIMENTAL
Intervention: Dimethylamine (DMA)
Number of subjects: 20
Study 15767770 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimethylamine (TMA)
Number of subjects: 20
Study 15767770 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium lauryl sulphate (SLS)
Number of subjects: 20
Study 15767770 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetic acid (AA)
Number of subjects: 20
Study 15767770 — intervention group
Group type: EXPERIMENTAL
Intervention: SLS combined with biogenic amines
Number of subjects: 20
Study 14641968 — intervention group
Group type: EXPERIMENTAL
Intervention: Olestra
Number of subjects: 14
Study 14641968 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise intervention study
Number of subjects: 14
Study 10622480 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed-wedge osteotomy (HTO, n 16)
Number of subjects: 33
Study 10622480 — intervention group
Group type: COMPARATOR
Intervention: Open-wedge osteotomy by hemicallotasis (HCO, n 19)
Number of subjects: 33
Study 10622480 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed-wedge osteotomy (HTO)
Number of subjects: 33
Study 8963856 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined surgery (CS)
Number of subjects: 26
Study 8963856 — intervention group
Group type: COMPARATOR
Intervention: Sequential surgery (SS)
Number of subjects: 26
Study 2045624 — intervention group
Group type: EXPERIMENTAL
Intervention: GHRH (1 microgram/Kg iv)
Number of subjects: 31
Study 2045624 — intervention group
Group type: EXPERIMENTAL
Intervention: Pyridostigmine (60 mg po)
Number of subjects: 31
Study 2045624 — intervention group
Group type: EXPERIMENTAL
Intervention: PD + GHRH (60 mg PD orally 60 min before GHRH)
Number of subjects: 31
Study 7389390 — intervention group
Group type: EXPERIMENTAL
Intervention: Single night-time dose of chlordiazepoxide (5 mg) and amitriptyline (12.5 mg) - 3 capsules as a single dose at night
Number of subjects: 80
Study 7389390 — intervention group
Group type: COMPARATOR
Intervention: Divided daily dosage regimen of chlordiazepoxide (5 mg) and amitriptyline (12.5 mg) - 1 capsule 3-times daily
Number of subjects: 80
Study 31813044 — intervention group
Group type: EXPERIMENTAL
Intervention: HIGH (1 hour high-intensity interval running session, 6×5 min at 90% VO2peak)
Number of subjects: 8
Study 31813044 — intervention group
Group type: EXPERIMENTAL
Intervention: LOW (1 hour low-intensity running session, 60 min at 45% VO2peak)
Number of subjects: 8
Study 31813044 — intervention group
Group type: COMPARATOR
Intervention: CON (no exercise)
Number of subjects: 8
Study 31608830 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep hygiene education (EG, n = 17)
Number of subjects: 29
Study 31608830 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG, n = 12)
Number of subjects: 29
Study 31608830 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep hygiene education (EG)
Number of subjects: 29
Study 31608830 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 29
Study 28084606 — intervention group
Group type: EXPERIMENTAL
Intervention: Mailed survey with phone follow-up
Number of subjects: 4000
Study 28084606 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive voice response (IVR) followed by mail
Number of subjects: 4000
Study 28084606 — intervention group
Group type: EXPERIMENTAL
Intervention: Email linked to web-based survey with mail follow-up
Number of subjects: 4000
Study 28084606 — intervention group
Group type: EXPERIMENTAL
Intervention: Email linked to web-based survey followed by IVR
Number of subjects: 4000
Study 28084606 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall response rate
Number of subjects: 4000
Study 28084606 — intervention group
Group type: COMPARATOR
Intervention: Non-Hispanic whites
Number of subjects: 4000
Study 28084606 — intervention group
Group type: COMPARATOR
Intervention: English speakers
Number of subjects: 4000
Study 28084606 — intervention group
Group type: COMPARATOR
Intervention: Higher socioeconomic status
Number of subjects: 4000
Study 25873137 — intervention group
Group type: EXPERIMENTAL
Intervention: internet-based cognitive behavior therapy (iCBT)
Number of subjects: 500
Study 25873137 — intervention group
Group type: COMPARATOR
Intervention: standard of care
Number of subjects: 500
Study 24163364 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (0.5 mg/kg)
Number of subjects: 32
Study 24163364 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 21318572 — intervention group
Group type: EXPERIMENTAL
Intervention: Romiplostim (1 μg/kg/week, escalated to 5 μg/kg/week, tapered over 12 weeks)
Number of subjects: 18
Study 21318572 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 20532105 — intervention group
Group type: COMPARATOR
Intervention: Oral midazolam 0.5 mg/kg mixed with ibuprofen 10 mg/kg (Group M)
Number of subjects: 92
Study 20532105 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral midazolam 0.5 mg/kg mixed with ibuprofen 10 mg/kg and ketamine 2 mg/kg (Group KM)
Number of subjects: 92
Study 17004125 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-compliance detection method
Number of subjects: 0
Study 17004125 — intervention group
Group type: COMPARATOR
Intervention: PK cleaned dataset
Number of subjects: 0
Study 14684640 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 11116493 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand-held NasOral System (NOS)
Number of subjects: 50
Study 11116493 — intervention group
Group type: COMPARATOR
Intervention: Nose mask fastened by rubber band
Number of subjects: 50
Study 11116493 — intervention group
Group type: COMPARATOR
Intervention: Face mask
Number of subjects: 50
Study 11116493 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand-held NOS
Number of subjects: 50
Study 9201140 — intervention group
Group type: EXPERIMENTAL
Intervention: IVIG 250 mg/kg/day for 2 days
Number of subjects: 24
Study 9201140 — intervention group
Group type: EXPERIMENTAL
Intervention: IVIG 400 mg/kg/day for 2 days
Number of subjects: 24
Study 9201140 — intervention group
Group type: EXPERIMENTAL
Intervention: IVIG 500 mg/kg/day for 2 days
Number of subjects: 24
Study 9201140 — intervention group
Group type: COMPARATOR
Intervention: IVIG 1 g/kg/day for 2 days (control)
Number of subjects: 24
Study 1488936 — intervention group
Group type: EXPERIMENTAL
Intervention: Role play with a confederate and visual cues
Number of subjects: 56
Study 1488936 — intervention group
Group type: EXPERIMENTAL
Intervention: Role play with a confederate and no cues
Number of subjects: 56
Study 1488936 — intervention group
Group type: EXPERIMENTAL
Intervention: Role play with a confederate and visual plus olfactory cues
Number of subjects: 56
Study 1488936 — intervention group
Group type: COMPARATOR
Intervention: Confederate absent with no cues
Number of subjects: 56
Study 1488936 — intervention group
Group type: COMPARATOR
Intervention: Confederate absent with visual cues
Number of subjects: 56
Study 1488936 — intervention group
Group type: COMPARATOR
Intervention: Confederate absent with visual plus olfactory cues
Number of subjects: 56
Study 4022376 — intervention group
Group type: EXPERIMENTAL
Intervention: Naproxen sodium
Number of subjects: 0
Study 4022376 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 31445626 — intervention group
Group type: EXPERIMENTAL
Intervention: Colloidal silver-impregnated wipe with sterile screw-top urine collection container (Group B)
Number of subjects: 223
Study 31445626 — intervention group
Group type: COMPARATOR
Intervention: Castile-soap wipe with sterile screw-top urine collection container (Group A)
Number of subjects: 223
Study 31445626 — intervention group
Group type: EXPERIMENTAL
Intervention: Colloidal silver-impregnated wipe with sterile urine-collection funnel (Group D)
Number of subjects: 223
Study 31445626 — intervention group
Group type: EXPERIMENTAL
Intervention: Castile-soap wipe with sterile urine-collection funnel (Group C)
Number of subjects: 223
Study 29406431 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate HIV assisted partner services (APS)
Number of subjects: 1119
Study 29406431 — intervention group
Group type: COMPARATOR
Intervention: Delayed HIV assisted partner services (APS) for 6 weeks
Number of subjects: 1119
Study 27632848 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength‐ and plyometric‐training group
Number of subjects: 40
Study 27632848 — intervention group
Group type: COMPARATOR
Intervention: Strength‐training group
Number of subjects: 40
Study 27632848 — intervention group
Group type: EXPERIMENTAL
Intervention: Plyometric‐training group
Number of subjects: 40
Study 24526895 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychotherapeutic Intervention Module (PIM), n = 90, six therapy sessions over two months.
Number of subjects: 173
Study 24526895 — intervention group
Group type: COMPARATOR
Intervention: Treatment as Usual (TAU), n = 83.
Number of subjects: 173
Study 23409602 — intervention group
Group type: EXPERIMENTAL
Intervention: Within-trials change group (target velocity changed from 4 to 8 m/sec during the trial)
Number of subjects: 14
Study 23409602 — intervention group
Group type: COMPARATOR
Intervention: Inter-trials change group (initial velocity remained constant at 4 or 8 m/sec)
Number of subjects: 14
Study 20102918 — intervention group
Group type: EXPERIMENTAL
Intervention: Red yeast rice 2,400 mg twice daily
Number of subjects: 43
Study 20102918 — intervention group
Group type: COMPARATOR
Intervention: Pravastatin 20 mg twice daily
Number of subjects: 43
Study 18545692 — intervention group
Group type: EXPERIMENTAL
Intervention: Dihydroartemisinin-piperaquine (DP)
Number of subjects: 414
Study 18545692 — intervention group
Group type: COMPARATOR
Intervention: Artemether-lumefantrine (AL)
Number of subjects: 414
Study 15845714 — intervention group
Group type: EXPERIMENTAL
Intervention: CSE (combined spinal-epidural technique)
Number of subjects: 60
Study 15845714 — intervention group
Group type: COMPARATOR
Intervention: SSS (single-shot spinal technique)
Number of subjects: 60
Study 12460724 — intervention group
Group type: EXPERIMENTAL
Intervention: Reactive hyperemia (RH) response in people with diabetes and amputation
Number of subjects: 88
Study 12460724 — intervention group
Group type: EXPERIMENTAL
Intervention: Reactive hyperemia (RH) response in smokers
Number of subjects: 88
Study 12460724 — intervention group
Group type: EXPERIMENTAL
Intervention: Reactive hyperemia (RH) response in vasodilator users
Number of subjects: 88
Study 12460724 — intervention group
Group type: EXPERIMENTAL
Intervention: Reactive hyperemia (RH) response across skin pigmentation
Number of subjects: 88
Study 12460724 — intervention group
Group type: EXPERIMENTAL
Intervention: Reactive hyperemia (RH) response across age
Number of subjects: 88
Study 10027684 — intervention group
Group type: EXPERIMENTAL
Intervention: Diary card measure
Number of subjects: 0
Study 10027684 — intervention group
Group type: EXPERIMENTAL
Intervention: Symptom question in a gastrointestinal symptom questionnaire
Number of subjects: 0
Study 10027684 — intervention group
Group type: EXPERIMENTAL
Intervention: Symptom severity rating made by the investigator
Number of subjects: 0
Study 7608363 — intervention group
Group type: EXPERIMENTAL
Intervention: Notebook training
Number of subjects: 8
Study 7608363 — intervention group
Group type: COMPARATOR
Intervention: Supportive therapy
Number of subjects: 8
Study 2198381 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisapride 20 mg orally
Number of subjects: 22
Study 2198381 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 676877 — intervention group
Group type: EXPERIMENTAL
Intervention: Gentamicin (1.0 mg/kg body-weight)
Number of subjects: 12
Study 676877 — intervention group
Group type: EXPERIMENTAL
Intervention: Sisomicin (1.0 mg/kg body-weight)
Number of subjects: 12
Study 676877 — intervention group
Group type: EXPERIMENTAL
Intervention: Amikacin (one-hour constant infusion)
Number of subjects: 12
Study 676877 — intervention group
Group type: EXPERIMENTAL
Intervention: Tobramycin (1.0 mg/kg body-weight)
Number of subjects: 12
Study 31074198 — intervention group
Group type: EXPERIMENTAL
Intervention: Inspiratory Muscle Training (IMT)
Number of subjects: 59
Study 31074198 — intervention group
Group type: COMPARATOR
Intervention: Sham-IMT
Number of subjects: 59
Study 30359890 — intervention group
Group type: EXPERIMENTAL
Intervention: Social feedback that one scene was not experienced
Number of subjects: 0
Study 30359890 — intervention group
Group type: EXPERIMENTAL
Intervention: Objective false evidence that one of the scenes was not shown
Number of subjects: 0
Study 30359890 — intervention group
Group type: EXPERIMENTAL
Intervention: Both social feedback and objective false evidence
Number of subjects: 0
Study 30359890 — intervention group
Group type: COMPARATOR
Intervention: Control group (no manipulation)
Number of subjects: 0
Study 28278309 — intervention group
Group type: EXPERIMENTAL
Intervention: High adherence to the Mediterranean diet (>35/55 score)
Number of subjects: 343
Study 28278309 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium adherence to the Mediterranean diet
Number of subjects: 343
Study 28278309 — intervention group
Group type: COMPARATOR
Intervention: Low adherence to the Mediterranean diet
Number of subjects: 343
Study 24909787 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive residential treatment (IRT)
Number of subjects: 281
Study 24909787 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive residential treatment (IRT) responders
Number of subjects: 281
Study 24909787 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive residential treatment (IRT) participants who achieved wellness
Number of subjects: 281
Study 22750086 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased sample size to 3000 and follow-up for one year after recruitment
Number of subjects: 3000
Study 21041811 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet rich in pulses and wholegrains (2 serves of pulses and 4 serves of wholegrain foods per day)
Number of subjects: 113
Study 21041811 — intervention group
Group type: COMPARATOR
Intervention: Control diet (not specified)
Number of subjects: 113
Study 21041811 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (intervention and control)
Number of subjects: 113
Study 17413195 — intervention group
Group type: EXPERIMENTAL
Intervention: Gastric lavage with mother's milk (BML group)
Number of subjects: 80
Study 17413195 — intervention group
Group type: COMPARATOR
Intervention: Nil per orally (NPO group)
Number of subjects: 80
Study 16306540 — intervention group
Group type: COMPARATOR
Intervention: DASH diet
Number of subjects: 116
Study 16306540 — intervention group
Group type: COMPARATOR
Intervention: Weight-reducing diet
Number of subjects: 116
Study 12471293 — intervention group
Group type: EXPERIMENTAL
Intervention: Active warm-up
Number of subjects: 43
Study 12471293 — intervention group
Group type: COMPARATOR
Intervention: High-heat passive warm-up before eccentric exercise
Number of subjects: 43
Study 12471293 — intervention group
Group type: EXPERIMENTAL
Intervention: Eccentric exercise without warm-up
Number of subjects: 43
Study 12471293 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-heat passive warm-up
Number of subjects: 43
Study 12471293 — intervention group
Group type: EXPERIMENTAL
Intervention: High-heat passive warm-up without eccentric exercise
Number of subjects: 43
Study 9836546 — intervention group
Group type: EXPERIMENTAL
Intervention: pT1a tumors
Number of subjects: 124
Study 9836546 — intervention group
Group type: EXPERIMENTAL
Intervention: pT1b tumors
Number of subjects: 124
Study 9836546 — intervention group
Group type: EXPERIMENTAL
Intervention: pT1c tumors
Number of subjects: 124
Study 9836546 — intervention group
Group type: COMPARATOR
Intervention: Absence of CIS in the tumor
Number of subjects: 124
Study 9836546 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of CIS in the tumor
Number of subjects: 124
Study 9836546 — intervention group
Group type: COMPARATOR
Intervention: Absence of CIS in biopsy specimens
Number of subjects: 124
Study 9836546 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of CIS in biopsy specimens
Number of subjects: 124
Study 9836546 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of pT1c and CIS
Number of subjects: 124
Study 7926138 — intervention group
Group type: EXPERIMENTAL
Intervention: Veralipride 100 mg/d
Number of subjects: 40
Study 2913138 — intervention group
Group type: EXPERIMENTAL
Intervention: Active treatment with cat-dander extracts for 2 years (group A)
Number of subjects: 35
Study 2913138 — intervention group
Group type: COMPARATOR
Intervention: Active treatment with cat-dander extracts for 1 year (group B)
Number of subjects: 35
Study 4883848 — intervention group
Group type: EXPERIMENTAL
Intervention: Preseasonal Allpyral
Number of subjects: 300
Study 4883848 — intervention group
Group type: EXPERIMENTAL
Intervention: Depo‐Medrone
Number of subjects: 300
Study 4883848 — intervention group
Group type: COMPARATOR
Intervention: Coseasonal Allpyral
Number of subjects: 300
Study 387054 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrous oxide 50% in oxygen (Entonox) during chest physiotherapy
Number of subjects: 12
Study 387054 — intervention group
Group type: COMPARATOR
Intervention: Oxygen 100% during chest physiotherapy
Number of subjects: 12
Study 387054 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrous oxide 50% in oxygen (Entonox) without chest physiotherapy
Number of subjects: 12
Study 387054 — intervention group
Group type: EXPERIMENTAL
Intervention: Withdrawal of nitrous oxide
Number of subjects: 12
Study 31030188 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical thrombectomy (MT)
Number of subjects: 79
Study 27388589 — intervention group
Group type: EXPERIMENTAL
Intervention: Liquid levothyroxine formulation
Number of subjects: 155
Study 27388589 — intervention group
Group type: COMPARATOR
Intervention: Tablet levothyroxine formulation
Number of subjects: 155
Study 27388589 — intervention group
Group type: EXPERIMENTAL
Intervention: Levothyroxine replacement therapy (both formulations)
Number of subjects: 155
Study 26018817 — intervention group
Group type: EXPERIMENTAL
Intervention: Nursing interventions based on the Health Belief Model and the Health Promotion Model
Number of subjects: 200
Study 26018817 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 200
Study 25438937 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose oral vitamin D3 (6000 IU daily for 6 months)
Number of subjects: 50
Study 25438937 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 22560018 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-blocker (BB) dose
Number of subjects: 2331
Study 22560018 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher doses of BB
Number of subjects: 2331
Study 19346625 — intervention group
Group type: EXPERIMENTAL
Intervention: Elastic resistance exercise program for 4 weeks
Number of subjects: 40
Study 19346625 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 40
Study 17470957 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive remediation therapy (40 sessions)
Number of subjects: 85
Study 17470957 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 85
Study 15182896 — intervention group
Group type: EXPERIMENTAL
Intervention: Network therapy (NT)
Number of subjects: 66
Study 15182896 — intervention group
Group type: COMPARATOR
Intervention: Medication management (MM)
Number of subjects: 66
Study 12394686 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravesical bacillus Calmette-Guerin (BCG)
Number of subjects: 4863